Pancreatic cancer is another disease that could benefit from a blood-based diagnostic test. Unlike colon cancer, pancreatic ...

Pancreatic cancer is one of the deadliest forms of cancer, largely because it’s so difficult to catch early. By the time it’s ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer Discovery Analysis Demonstrates Transformative Sensitivity of 95% ...

Mainz Biomed (MYNZ) announced it has entered into a License and Option Agreement with Liquid Biosciences to access a portfolio of novel mRNA ...

Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

These vaccines work by stimulating the body's immune response against cancer cells, often by training immune cells (like T cells) to target specific tumor proteins. Listen to Story A new personalised ...

A renowned medical school whose faculty helped treat a young cancer survivor honored this week by President Donald Trump is facing potentially devastating funding cuts because of the White House.

Scientists have secured £1.5 million from Cancer Research UK (CRUK) to investigate the genetic secrets behind neuroblastoma - aiming to improve treatments for this aggressive childhood cancer.

3.3 Pathways for the transdifferentiation of α-cell to β-cell Transdifferentiation of α-cells to β-cells is a key demonstration of endocrine cell plasticity within pancreatic islets, involving a ...